Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06907147 · ClinicalTrials.gov registry record · NA
SPYRAL GEMINI Pilot Study
A NA study of Hypertension and Cardiovascular Diseases, sponsored by Medtronic Vascular.
- Recruiting
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 13
- Study locations
NCT06907147 is a NA study of Hypertension and Cardiovascular Diseases that is actively recruiting participants, run by Medtronic Vascular. The registered enrollment target is 175 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 13 study locations across 9 states.
The verdict
NCT06907147, a NA study of Hypertension and Cardiovascular Diseases, is actively recruiting participants, sponsored by Medtronic Vascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.
Conditions Studied
Interventions
- DEVICE Multi-Organ Denervation Gemini System
Study Locations (13)
Other
- Royal Perth Hospital (Dobney Hypertension Centre) - Perth
- Hippokration General Hospital - Athens
- University Hospital of Galway - Galway
- University Hospital Basel - Basel
Texas
- Baylor Heart & Vascular Hospital - Dallas
- UT Health East Texas - Tyler
California
- Stanford Hospital and Clinics - Stanford
Georgia
- Piedmont Heart Institute - Atlanta
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- Henry Ford Providence Hospital - Southfield
Mississippi
- North Mississippi Medical Center - Tupelo
Nevada
- Renown Regional Medical Center - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2029-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06907147
The ClinicalTrials.gov registry entry for NCT06907147 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Multi-Organ Denervation Gemini System is the first listed.
NCT06907147 reports 13 study locations spanning 9 distinct geographic areas - top geographies include Other, Texas, California.
Frequently Asked Questions
What is clinical trial NCT06907147 about?
NCT06907147 is a clinical study titled "SPYRAL GEMINI Pilot Study". The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.
What is the current status of trial NCT06907147?
This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2025-05-01. Estimated completion is 2029-12-22.
What conditions does trial NCT06907147 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Diabetes Mellitus, Chronic Kidney Diseases, Vascular Diseases.
What interventions are being tested in trial NCT06907147?
The interventions under investigation include: Multi-Organ Denervation Gemini System (DEVICE).
Who is sponsoring clinical trial NCT06907147?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06907147 being conducted?
This trial has 13 study locations across California, Georgia, Massachusetts, Michigan, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.